Synthesis of nucleusidyl rifamycins as inhibitors of human immunodeficiency virus type 1

被引：0
|
作者：
Bartolucci, C.
Cellai, L.
Mannina, L.
Marzano, M.
机构：
来源：
Antiviral Chemistry & Chemotherapy | / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication
    Miller, Leia K.
    Kobayashi, Yoshifumi
    Chen, Chiann-Chyi
    Russnak, Timothy A.
    Ron, Yacov
    Dougherty, Joseph P.
    RETROVIROLOGY, 2013, 10
  • [42] NATURAL COMPOUNDS FROM PLANTS OF THE CLUSIACEAE FAMILY: TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS INHIBITORS
    Reyes Chilpa, Ricardo
    Huerta Reyes, Maira
    INTERCIENCIA, 2009, 34 (06) : 385 - 392
  • [43] Reverse transcription of human immunodeficiency virus type 1 is blocked by retroviral zinc finger inhibitors
    Turpin, JA
    Schaeffer, CA
    Terpening, SJ
    Graham, L
    Bu, M
    Rice, WG
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (01): : 60 - 69
  • [44] Growth in human immunodeficiency virus type 1- infected children treated with protease inhibitors
    Felicitas Steiner
    Christian Kind
    Christoph Aebi
    Claire-Anne Wyler-Lazarevitch
    Jean-Jacques Cheseaux
    Christoph Rudin
    Luciano Molinari
    David Nadal
    European Journal of Pediatrics, 2001, 160 : 611 - 616
  • [45] Targeting Tn5 transposase identifies human immunodeficiency virus type 1 inhibitors
    Ason, B
    Knauss, DJ
    Balke, AM
    Merkel, G
    Skalka, AM
    Reznikoff, WS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) : 2035 - 2043
  • [46] Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication
    Leia K Miller
    Yoshifumi Kobayashi
    Chiann-Chyi Chen
    Timothy A Russnak
    Yacov Ron
    Joseph P Dougherty
    Retrovirology, 10
  • [47] Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitors
    Watkins, T
    Resch, W
    Irlbeck, D
    Swanstrom, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 759 - 769
  • [48] KINETICS OF DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASES RESISTANT TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DEBYSER, Z
    DEVREESE, K
    KNOPSGERRITS, PP
    BAEKELANDT, V
    BHIKHABHAI, R
    STRANDBERG, B
    PAUWELS, R
    ANNE, J
    DESMYTER, J
    DE CLERCQ, E
    MOLECULAR PHARMACOLOGY, 1993, 43 (04) : 521 - 526
  • [49] Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1
    Crise, B
    Li, Y
    Yuan, CC
    Morcock, DR
    Whitby, D
    Munroe, DJ
    Arthur, LO
    Wu, XL
    JOURNAL OF VIROLOGY, 2005, 79 (19) : 12199 - 12204
  • [50] Oligonucleotides as inhibitors of human immunodeficiency virus
    Field, AK
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 1999, 1 (03) : 323 - 331
12345